Last Viewed
| Most Viewed
|
DVLA - PT Darya-Varia Laboratoria TbkSector : Healthcare Industry : Drug Manufacturers—Specialty & GenericPT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. It also offers Consumer Health products comprising Skin Nutrition under the Natur-E brand; Respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brand names for nasal congestion, cough, as well as breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; and supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. In addition, the company offers toll manufacturing services for soft gelatin capsules, and sterile injections and low volume solid products. It also exports its products to Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd. |
|
Dataid | Breakdown | Seq | TTM | 2023-12-31 | 2022-12-31 |
---|---|---|---|---|---|
14008 | Pe Ratio | 1 | 11 | 23 | 59 |
102 | Enterprises Value E B I T D A Ratio | 5 | 6 | 10 | -704 |
40001 | Market Cap | 8 | 1,663,200,000,000 | 1,864,800,000,000 | 2,654,400,000,000 |
14010 | Ps Ratio | 12 | 1 | 1 | 1 |
14012 | Pb Ratio | 15 | 1 | 1 | 2 |
40002 | Enterprise Value | 22 | 1,424,631,053,000 | 1,525,409,035,000 | 2,272,442,449,000 |
101 | Enterprises Value Revenue Ratio | 32 | 1 | 1 | 6 |
Dataid | Breakdown | Seq | TTM | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
---|---|---|---|---|---|---|---|---|---|
14008 | Pe Ratio | 1 | 11 | 11 | 23 | 29 | 30 | 15 | 59 |
102 | Enterprises Value E B I T D A Ratio | 5 | 6 | 6 | 10 | 14 | 14 | 8 | -704 |
40001 | Market Cap | 8 | 1,663,200,000,000 | 1,635,200,000,000 | 1,864,800,000,000 | 2,234,400,000,000 | 2,206,400,000,000 | 2,206,400,000,000 | 2,654,400,000,000 |
14010 | Ps Ratio | 12 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
14012 | Pb Ratio | 15 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
40002 | Enterprise Value | 22 | 1,424,631,053,000 | 1,396,631,053,000 | 1,525,409,035,000 | 1,919,355,896,000 | 1,900,519,606,000 | 1,851,267,208,000 | 2,272,442,449,000 |
101 | Enterprises Value Revenue Ratio | 32 | 1 | 1 | 1 | 1 | 1 | 1 | 6 |
Dataid | Breakdown | Seq | TTM | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|
20189 | E B I T | 0 | 203,457,868,000 | 60,699,641,000 | 201,244,366,000 | 211,634,677,000 | 214,147,761,000 |
20091 | Net Income | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
29004 | Basic E P S | 0 | 137 | 0 | 133 | 131 | 145 |
20190 | E B I T D A | 0 | 239,384,022,000 | 70,715,695,000 | 234,366,566,000 | 247,358,820,000 | 245,997,864,000 |
20007 | Amortization | 0 | 4,897,412,000 | 1,224,353,000 | 4,897,412,000 | 4,284,549,000 | 0 |
20046 | Gross Profit | 0 | 998,575,029,000 | 286,982,018,000 | 1,006,123,382,000 | 995,768,212,000 | 931,988,668,000 |
29009 | Diluted E P S | 0 | 137 | 0 | 133 | 131 | 145 |
20136 | Pretax Income | 0 | 203,393,752,000 | 60,684,130,000 | 201,073,217,000 | 211,511,203,000 | 214,069,167,000 |
20145 | Tax Provision | 0 | 50,483,160,000 | 14,166,766,000 | 51,698,206,000 | 65,005,866,000 | 51,996,183,000 |
20100 | Total Revenue | 0 | 1,910,016,244,000 | 541,368,625,000 | 1,917,041,442,000 | 1,900,893,602,000 | 1,829,699,557,000 |
20164 | Total Expenses | 0 | 1,716,176,967,000 | 459,314,803,000 | 1,742,069,501,000 | 1,712,025,091,000 | 1,625,689,443,000 |
20013 | Cost Of Revenue | 0 | 911,441,215,000 | 254,386,607,000 | 910,918,060,000 | 905,125,390,000 | 897,710,889,000 |
20177 | Interest Income | 0 | 1,925,461,000 | 409,364,000 | 3,621,237,000 | 4,143,833,000 | 3,431,655,000 |
20057 | Interest Expense | 0 | 64,116,000 | 15,511,000 | 171,149,000 | 123,474,000 | 78,594,000 |
20109 | Operating Income | 0 | 193,839,277,000 | 82,053,822,000 | 174,971,941,000 | 188,868,511,000 | 204,010,114,000 |
20316 | Normalized Income | 0 | 150,100,981,808 | 45,390,589,745 | 148,460,927,373 | 145,688,597,423 | 162,451,878,299 |
20108 | Operating Expense | 0 | 804,735,752,000 | 204,928,196,000 | 831,151,441,000 | 806,899,701,000 | 727,978,554,000 |
20112 | Operating Revenue | 0 | 1,910,016,244,000 | 541,368,625,000 | 1,917,041,442,000 | 1,900,893,602,000 | 1,829,699,557,000 |
20418 | Tax Rate For Calcs | 0 | 0 | 0 | 0 | 0 | 0 |
20095 | Net Interest Income | 0 | 1,562,608,000 | 314,895,000 | 3,115,552,000 | 3,643,054,000 | 3,004,033,000 |
20416 | Total Unusual Items | 0 | 3,737,198,000 | 1,469,931,000 | 1,230,445,000 | 1,179,135,000 | -500,451,000 |
29010 | Basic Average Shares | 0 | 1,120,000,000 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
20269 | Other Special Charges | 0 | -3,737,198,000 | -1,469,931,000 | -1,230,445,000 | -1,179,135,000 | 500,451,000 |
20287 | Rent And Landing Fees | 0 | 13,900,429,000 | 3,783,492,000 | 15,912,361,000 | 10,370,142,000 | 12,964,424,000 |
29011 | Diluted Average Shares | 0 | 1,120,000,000 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
20420 | Normalized E B I T D A | 0 | 235,646,824,000 | 69,245,764,000 | 233,136,121,000 | 246,179,685,000 | 246,498,315,000 |
20162 | Special Income Charges | 0 | 3,737,198,000 | 1,469,931,000 | 1,230,445,000 | 1,179,135,000 | -500,451,000 |
20315 | Reconciled Depreciation | 0 | 35,926,154,000 | 10,016,054,000 | 33,122,200,000 | 35,724,143,000 | 31,850,103,000 |
20312 | Other Operating Expenses | 0 | 2,833,693,000 | 642,005,000 | -3,413,553,000 | -560,586,000 | 22,245,974,000 |
20151 | Research And Development | 0 | 30,658,194,000 | 10,354,862,000 | 25,013,285,000 | 40,300,245,000 | 26,303,077,000 |
20368 | Total Other Finance Cost | 0 | 298,737,000 | 78,958,000 | 334,536,000 | 377,305,000 | 349,028,000 |
20440 | Rent Expense Supplemental | 0 | 13,900,429,000 | 3,783,492,000 | 15,912,361,000 | 10,370,142,000 | 12,964,424,000 |
20314 | Reconciled Cost Of Revenue | 0 | 911,441,215,000 | 254,386,607,000 | 910,918,060,000 | 905,125,390,000 | 897,710,889,000 |
20419 | Tax Effect Of Unusual Items | 0 | 927,587,808 | 343,156,745 | 316,361,373 | 362,395,423 | -121,556,701 |
20018 | Depreciation Income Statement | 0 | 31,028,742,000 | 8,791,701,000 | 28,224,788,000 | 31,439,594,000 | 31,850,103,000 |
20075 | Interest Income Non Operating | 0 | 1,925,461,000 | 409,364,000 | 3,621,237,000 | 4,143,833,000 | 3,431,655,000 |
20158 | Selling And Marketing Expense | 0 | 375,050,854,000 | 92,253,047,000 | 412,413,098,000 | 408,392,887,000 | 338,481,421,000 |
20064 | Interest Expense Non Operating | 0 | 64,116,000 | 15,511,000 | 171,149,000 | 123,474,000 | 78,594,000 |
20093 | Net Income Common Stockholders | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20094 | Net Income Continuous Operations | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20045 | General And Administrative Expense | 0 | 97,167,632,000 | 26,092,967,000 | 96,697,740,000 | 88,439,440,000 | 78,566,555,000 |
20159 | Selling General And Administration | 0 | 472,218,486,000 | 118,346,014,000 | 509,110,838,000 | 496,832,327,000 | 417,047,976,000 |
20435 | Total Operating Income As Reported | 0 | 201,917,500,000 | 60,372,150,000 | 198,347,376,000 | 208,319,611,000 | 210,716,106,000 |
20412 | Other Non Operating Income Expenses | 0 | 2,512,672,000 | -21,791,080,000 | 15,328,145,000 | 6,928,254,000 | 5,700,222,000 |
20347 | Otherunder Preferred Stock Dividend | 0 | 0 | 0 | 0 | 0 | 0 |
20424 | Diluted N I Availto Com Stockholders | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20417 | Total Unusual Items Excluding Goodwill | 0 | 3,737,198,000 | 1,469,931,000 | 1,230,445,000 | 1,179,135,000 | -500,451,000 |
20077 | Net Non Operating Interest Income Expense | 0 | 1,562,608,000 | 314,895,000 | 3,115,552,000 | 3,643,054,000 | 3,004,033,000 |
20346 | Net Income Including Noncontrolling Interests | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20019 | Depreciation And Amortization In Income Statement | 0 | 35,926,154,000 | 10,016,054,000 | 33,122,200,000 | 35,724,143,000 | 31,850,103,000 |
20309 | Net Income From Continuing And Discontinued Operation | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20331 | Net Income From Continuing Operation Net Minority Interest | 0 | 152,910,592,000 | 46,517,364,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
Dataid | Breakdown | Seq | TTM | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|
20189 | E B I T | 0 | 203,457,868,000 | 91,189,206,000 | 60,699,641,000 | 4,639,870,000 | 46,929,151,000 | 79,437,879,000 | 201,244,366,000 | 211,634,677,000 | 214,147,761,000 |
20091 | Net Income | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
29004 | Basic E P S | 0 | 137 | 60 | 0 | 74 | 0 | 54 | 133 | 131 | 145 |
20190 | E B I T D A | 0 | 239,384,022,000 | 100,149,049,000 | 70,715,695,000 | 13,189,618,000 | 55,329,660,000 | 87,911,491,000 | 234,366,566,000 | 247,358,820,000 | 245,997,864,000 |
20007 | Amortization | 0 | 4,897,412,000 | 1,224,353,000 | 1,224,353,000 | 1,224,353,000 | 1,224,353,000 | 1,224,353,000 | 4,897,412,000 | 4,284,549,000 | 0 |
20046 | Gross Profit | 0 | 998,575,029,000 | 284,647,309,000 | 286,982,018,000 | 180,166,381,000 | 246,779,321,000 | 261,311,907,000 | 1,006,123,382,000 | 995,768,212,000 | 931,988,668,000 |
29009 | Diluted E P S | 0 | 137 | 60 | 0 | 74 | 0 | 54 | 133 | 131 | 145 |
20136 | Pretax Income | 0 | 203,393,752,000 | 91,174,753,000 | 60,684,130,000 | 4,623,313,000 | 46,911,556,000 | 79,419,259,000 | 201,073,217,000 | 211,511,203,000 | 214,069,167,000 |
20145 | Tax Provision | 0 | 50,483,160,000 | 23,685,646,000 | 14,166,766,000 | 1,116,881,000 | 11,513,867,000 | 18,504,379,000 | 51,698,206,000 | 65,005,866,000 | 51,996,183,000 |
20100 | Total Revenue | 0 | 1,910,016,244,000 | 532,286,781,000 | 541,368,625,000 | 367,083,676,000 | 469,277,162,000 | 513,158,043,000 | 1,917,041,442,000 | 1,900,893,602,000 | 1,829,699,557,000 |
20164 | Total Expenses | 0 | 1,716,176,967,000 | 445,004,992,000 | 459,314,803,000 | 380,411,300,000 | 431,445,872,000 | 442,406,396,000 | 1,742,069,501,000 | 1,712,025,091,000 | 1,625,689,443,000 |
20013 | Cost Of Revenue | 0 | 911,441,215,000 | 247,639,472,000 | 254,386,607,000 | 186,917,295,000 | 222,497,841,000 | 251,846,136,000 | 910,918,060,000 | 905,125,390,000 | 897,710,889,000 |
20177 | Interest Income | 0 | 1,925,461,000 | 399,655,000 | 409,364,000 | 623,270,000 | 493,172,000 | 544,857,000 | 3,621,237,000 | 4,143,833,000 | 3,431,655,000 |
20057 | Interest Expense | 0 | 64,116,000 | 14,453,000 | 15,511,000 | 16,557,000 | 17,595,000 | 18,620,000 | 171,149,000 | 123,474,000 | 78,594,000 |
20109 | Operating Income | 0 | 193,839,277,000 | 87,281,789,000 | 82,053,822,000 | -13,327,624,000 | 37,831,290,000 | 70,751,647,000 | 174,971,941,000 | 188,868,511,000 | 204,010,114,000 |
20316 | Normalized Income | 0 | 150,100,981,808 | 66,966,331,667 | 45,390,589,745 | 2,852,509,640 | 34,870,394,112 | 60,593,679,483 | 148,460,927,373 | 145,688,597,423 | 162,451,878,299 |
20108 | Operating Expense | 0 | 804,735,752,000 | 197,365,520,000 | 204,928,196,000 | 193,494,005,000 | 208,948,031,000 | 190,560,260,000 | 831,151,441,000 | 806,899,701,000 | 727,978,554,000 |
20112 | Operating Revenue | 0 | 1,910,016,244,000 | 532,286,781,000 | 541,368,625,000 | 367,083,676,000 | 469,277,162,000 | 513,158,043,000 | 1,917,041,442,000 | 1,900,893,602,000 | 1,829,699,557,000 |
20418 | Tax Rate For Calcs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20095 | Net Interest Income | 0 | 1,562,608,000 | 316,419,000 | 314,895,000 | 533,120,000 | 398,174,000 | 443,051,000 | 3,115,552,000 | 3,643,054,000 | 3,004,033,000 |
20416 | Total Unusual Items | 0 | 3,737,198,000 | 706,246,000 | 1,469,931,000 | 862,212,000 | 698,809,000 | 418,773,000 | 1,230,445,000 | 1,179,135,000 | -500,451,000 |
29010 | Basic Average Shares | 0 | 1,120,000,000 | 1,120,000,000 | 0 | 1,120,000,000 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
20269 | Other Special Charges | 0 | -3,737,198,000 | -706,246,000 | -1,469,931,000 | -862,212,000 | -698,809,000 | -418,773,000 | -1,230,445,000 | -1,179,135,000 | 500,451,000 |
20287 | Rent And Landing Fees | 0 | 13,900,429,000 | 2,630,233,000 | 3,783,492,000 | 3,972,939,000 | 3,513,765,000 | 3,079,689,000 | 15,912,361,000 | 10,370,142,000 | 12,964,424,000 |
29011 | Diluted Average Shares | 0 | 1,120,000,000 | 1,120,000,000 | 0 | 1,120,000,000 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
20420 | Normalized E B I T D A | 0 | 235,646,824,000 | 99,442,803,000 | 69,245,764,000 | 12,327,406,000 | 54,630,851,000 | 87,492,718,000 | 233,136,121,000 | 246,179,685,000 | 246,498,315,000 |
20162 | Special Income Charges | 0 | 3,737,198,000 | 706,246,000 | 1,469,931,000 | 862,212,000 | 698,809,000 | 418,773,000 | 1,230,445,000 | 1,179,135,000 | -500,451,000 |
20315 | Reconciled Depreciation | 0 | 35,926,154,000 | 8,959,843,000 | 10,016,054,000 | 8,549,748,000 | 8,400,509,000 | 8,473,612,000 | 33,122,200,000 | 35,724,143,000 | 31,850,103,000 |
20312 | Other Operating Expenses | 0 | 2,833,693,000 | 2,395,030,000 | 642,005,000 | -2,227,527,000 | 2,024,185,000 | 683,353,000 | -3,413,553,000 | -560,586,000 | 22,245,974,000 |
20151 | Research And Development | 0 | 30,658,194,000 | 0 | 10,354,862,000 | 7,988,263,000 | 0 | 0 | 25,013,285,000 | 40,300,245,000 | 26,303,077,000 |
20368 | Total Other Finance Cost | 0 | 298,737,000 | 68,783,000 | 78,958,000 | 73,593,000 | 77,403,000 | 83,186,000 | 334,536,000 | 377,305,000 | 349,028,000 |
20440 | Rent Expense Supplemental | 0 | 13,900,429,000 | 2,630,233,000 | 3,783,492,000 | 3,972,939,000 | 3,513,765,000 | 3,079,689,000 | 15,912,361,000 | 10,370,142,000 | 12,964,424,000 |
20314 | Reconciled Cost Of Revenue | 0 | 911,441,215,000 | 247,639,472,000 | 254,386,607,000 | 186,917,295,000 | 222,497,841,000 | 251,846,136,000 | 910,918,060,000 | 905,125,390,000 | 897,710,889,000 |
20419 | Tax Effect Of Unusual Items | 0 | 927,587,808 | 183,470,667 | 343,156,745 | 208,289,640 | 171,514,112 | 97,572,483 | 316,361,373 | 362,395,423 | -121,556,701 |
20018 | Depreciation Income Statement | 0 | 31,028,742,000 | 7,735,490,000 | 8,791,701,000 | 7,325,395,000 | 7,176,156,000 | 7,249,259,000 | 28,224,788,000 | 31,439,594,000 | 31,850,103,000 |
20075 | Interest Income Non Operating | 0 | 1,925,461,000 | 399,655,000 | 409,364,000 | 623,270,000 | 493,172,000 | 544,857,000 | 3,621,237,000 | 4,143,833,000 | 3,431,655,000 |
20158 | Selling And Marketing Expense | 0 | 375,050,854,000 | 86,727,835,000 | 92,253,047,000 | 94,934,061,000 | 101,135,911,000 | 76,907,357,000 | 412,413,098,000 | 408,392,887,000 | 338,481,421,000 |
20064 | Interest Expense Non Operating | 0 | 64,116,000 | 14,453,000 | 15,511,000 | 16,557,000 | 17,595,000 | 18,620,000 | 171,149,000 | 123,474,000 | 78,594,000 |
20093 | Net Income Common Stockholders | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20094 | Net Income Continuous Operations | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20045 | General And Administrative Expense | 0 | 97,167,632,000 | 22,365,673,000 | 26,092,967,000 | 23,967,359,000 | 24,741,633,000 | 21,350,166,000 | 96,697,740,000 | 88,439,440,000 | 78,566,555,000 |
20159 | Selling General And Administration | 0 | 472,218,486,000 | 109,093,508,000 | 118,346,014,000 | 118,901,420,000 | 125,877,544,000 | 98,257,523,000 | 509,110,838,000 | 496,832,327,000 | 417,047,976,000 |
20435 | Total Operating Income As Reported | 0 | 201,917,500,000 | 90,869,482,000 | 60,372,150,000 | 4,141,254,000 | 46,534,614,000 | 79,001,993,000 | 198,347,376,000 | 208,319,611,000 | 210,716,106,000 |
20412 | Other Non Operating Income Expenses | 0 | 2,512,672,000 | 1,300,565,000 | -21,791,080,000 | 13,946,872,000 | 9,056,315,000 | 11,076,172,000 | 15,328,145,000 | 6,928,254,000 | 5,700,222,000 |
20347 | Otherunder Preferred Stock Dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20424 | Diluted N I Availto Com Stockholders | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20417 | Total Unusual Items Excluding Goodwill | 0 | 3,737,198,000 | 706,246,000 | 1,469,931,000 | 862,212,000 | 698,809,000 | 418,773,000 | 1,230,445,000 | 1,179,135,000 | -500,451,000 |
20077 | Net Non Operating Interest Income Expense | 0 | 1,562,608,000 | 316,419,000 | 314,895,000 | 533,120,000 | 398,174,000 | 443,051,000 | 3,115,552,000 | 3,643,054,000 | 3,004,033,000 |
20346 | Net Income Including Noncontrolling Interests | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20019 | Depreciation And Amortization In Income Statement | 0 | 35,926,154,000 | 8,959,843,000 | 10,016,054,000 | 8,549,748,000 | 8,400,509,000 | 8,473,612,000 | 33,122,200,000 | 35,724,143,000 | 31,850,103,000 |
20309 | Net Income From Continuing And Discontinued Operation | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
20331 | Net Income From Continuing Operation Net Minority Interest | 0 | 152,910,592,000 | 67,489,107,000 | 46,517,364,000 | 3,506,432,000 | 35,397,689,000 | 60,914,880,000 | 149,375,011,000 | 146,505,337,000 | 162,072,984,000 |
Dataid | Breakdown | Seq | TTM | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|
23097 | Goodwill | 0 | 0 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 |
23165 | Payables | 0 | 0 | 136,769,801,000 | 161,186,550,000 | 235,393,990,000 | 164,531,644,000 |
23139 | Net P P E | 0 | 0 | 417,610,283,000 | 400,438,546,000 | 401,254,309,000 | 436,705,852,000 |
23351 | Properties | 0 | 0 | 0 | 0 | 0 | 0 |
23386 | Total Debt | 0 | 0 | 1,474,205,000 | 1,887,723,000 | 22,981,444,000 | 988,532,000 |
23100 | Gross P P E | 0 | 0 | 916,194,932,000 | 851,929,378,000 | 819,768,711,000 | 809,411,236,000 |
23038 | Common Stock | 0 | 0 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 |
23045 | Current Debt | 0 | 0 | 0 | 0 | 22,981,444,000 | 0 |
23532 | Share Issued | 0 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
23220 | Total Assets | 0 | 0 | 2,042,171,821,000 | 2,009,139,485,000 | 2,082,911,322,000 | 1,983,415,575,000 |
23027 | Capital Stock | 0 | 0 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 |
23382 | Other Payable | 0 | 0 | 6,998,771,000 | 46,908,742,000 | 71,420,859,000 | 69,975,729,000 |
23028 | Cash Financial | 0 | 0 | 227,043,152,000 | 334,020,515,000 | 378,296,075,000 | 242,312,464,000 |
23179 | Prepaid Assets | 0 | 0 | 19,074,685,000 | 18,528,440,000 | 41,873,209,000 | 38,928,449,000 |
23232 | Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
23385 | Working Capital | 0 | 0 | 936,651,976,000 | 965,629,768,000 | 931,560,214,000 | 844,398,351,000 |
23000 | Accounts Payable | 0 | 0 | 93,412,649,000 | 107,613,348,000 | 151,154,949,000 | 130,439,373,000 |
23029 | Cash Equivalents | 0 | 0 | 13,000,000,000 | 23,000,000,000 | 205,000,000,000 | 23,000,000,000 |
23245 | Invested Capital | 0 | 0 | 1,404,432,093,000 | 1,403,620,581,000 | 1,414,393,583,000 | 1,337,974,014,000 |
23340 | Other Properties | 0 | 0 | 0 | 0 | 0 | 2,232,086,000 |
23342 | Other Receivables | 0 | 0 | 33,048,395,000 | 7,991,236,000 | 3,104,074,000 | 8,283,396,000 |
23204 | Retained Earnings | 0 | 0 | 1,074,088,554,000 | 1,063,272,189,000 | 1,043,817,178,000 | 986,441,951,000 |
23217 | Total Tax Payable | 0 | 0 | 36,358,381,000 | 6,664,460,000 | 12,818,182,000 | 34,092,271,000 |
23001 | Accounts Receivable | 0 | 0 | 696,169,487,000 | 556,433,743,000 | 468,412,673,000 | 708,985,205,000 |
23280 | Common Stock Equity | 0 | 0 | 1,404,432,093,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23403 | Net Tangible Assets | 0 | 0 | 1,332,046,002,000 | 1,344,862,569,000 | 1,333,924,920,000 | 1,322,942,778,000 |
23215 | Stockholders Equity | 0 | 0 | 1,404,432,093,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23383 | Tangible Book Value | 0 | 0 | 1,332,046,002,000 | 1,344,862,569,000 | 1,333,924,920,000 | 1,322,942,778,000 |
23374 | Total Capitalization | 0 | 0 | 1,404,432,093,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23312 | Land And Improvements | 0 | 0 | 0 | 18,525,491,000 | 18,525,491,000 | 18,525,491,000 |
23393 | Ordinary Shares Number | 0 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
23395 | Treasury Shares Number | 0 | 0 | 0 | 0 | 0 | 0 |
23155 | Other Intangible Assets | 0 | 0 | 62,106,630,000 | 48,478,551,000 | 47,207,758,000 | 4,751,775,000 |
23008 | Accumulated Depreciation | 0 | 0 | -498,584,649,000 | -451,490,832,000 | -418,514,402,000 | -372,705,384,000 |
23282 | Construction In Progress | 0 | 0 | 36,169,619,000 | 14,258,424,000 | 30,895,540,000 | 78,569,561,000 |
23380 | Capital Lease Obligations | 0 | 0 | 1,474,205,000 | 1,887,723,000 | 0 | 988,532,000 |
23030 | Cash And Cash Equivalents | 0 | 0 | 240,043,152,000 | 357,020,515,000 | 583,296,075,000 | 265,312,464,000 |
23262 | Gross Accounts Receivable | 0 | 0 | 713,961,332,000 | 573,517,705,000 | 489,634,435,000 | 708,985,205,000 |
23012 | Additional Paid In Capital | 0 | 0 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 |
23275 | Buildings And Improvements | 0 | 0 | 392,529,005,000 | 369,245,422,000 | 364,694,534,000 | 347,821,296,000 |
23163 | Other Short Term Investments | 0 | 0 | 0 | 0 | 0 | 12,587,867,000 |
23020 | Available For Sale Securities | 0 | 0 | 0 | 7,788,789,000 | 5,922,548,000 | 40,910,882,000 |
23319 | Machinery Furniture Equipment | 0 | 0 | 487,496,308,000 | 449,900,041,000 | 405,653,146,000 | 362,262,802,000 |
23048 | Current Capital Lease Obligation | 0 | 0 | 430,440,000 | 413,517,000 | 0 | 988,532,000 |
23127 | Long Term Capital Lease Obligation | 0 | 0 | 1,043,765,000 | 1,474,206,000 | 0 | 0 |
23098 | Goodwill And Other Intangible Assets | 0 | 0 | 72,386,091,000 | 58,758,012,000 | 57,487,219,000 | 15,031,236,000 |
23261 | Total Equity Gross Minority Interest | 0 | 0 | 1,404,432,093,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23259 | Total Liabilities Net Minority Interest | 0 | 0 | 637,739,728,000 | 605,518,904,000 | 691,499,183,000 | 645,441,561,000 |
23046 | Current Debt And Capital Lease Obligation | 0 | 0 | 430,440,000 | 413,517,000 | 22,981,444,000 | 988,532,000 |
23266 | Allowance For Doubtful Accounts Receivable | 0 | 0 | -17,791,845,000 | -17,083,962,000 | -21,221,762,000 | -22,611,115,000 |
23124 | Long Term Debt And Capital Lease Obligation | 0 | 0 | 1,043,765,000 | 1,474,206,000 | 0 | 0 |
23344 | Non Current Pension And Other Postretirement Benefit Plans | 0 | 0 | 132,366,556,000 | 121,700,955,000 | 96,397,484,000 | 89,598,040,000 |
Dataid | Breakdown | Seq | TTM | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|
23097 | Goodwill | 0 | 0 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 | 10,279,461,000 |
23165 | Payables | 0 | 0 | 221,977,134,000 | 136,769,801,000 | 153,465,567,000 | 154,129,403,000 | 138,236,896,000 | 161,186,550,000 | 235,393,990,000 | 164,531,644,000 |
23139 | Net P P E | 0 | 0 | 427,547,062,000 | 417,610,283,000 | 396,216,547,000 | 386,619,895,000 | 391,151,930,000 | 400,438,546,000 | 401,254,309,000 | 436,705,852,000 |
23351 | Properties | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23386 | Total Debt | 0 | 0 | 1,368,209,000 | 1,474,205,000 | 1,579,145,000 | 1,683,037,000 | 1,785,893,000 | 1,887,723,000 | 22,981,444,000 | 988,532,000 |
23100 | Gross P P E | 0 | 0 | 936,483,665,000 | 916,194,932,000 | 883,256,874,000 | 862,191,250,000 | 855,608,864,000 | 851,929,378,000 | 819,768,711,000 | 809,411,236,000 |
23038 | Common Stock | 0 | 0 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 |
23045 | Current Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,981,444,000 | 0 |
23532 | Share Issued | 0 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
23220 | Total Assets | 0 | 0 | 2,200,407,426,000 | 2,042,171,821,000 | 2,007,726,972,000 | 2,096,368,646,000 | 2,053,330,647,000 | 2,009,139,485,000 | 2,082,911,322,000 | 1,983,415,575,000 |
23027 | Capital Stock | 0 | 0 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 | 280,000,000,000 |
23382 | Other Payable | 0 | 0 | 8,295,542,000 | 6,998,771,000 | 4,814,207,000 | 95,392,000 | 7,907,225,000 | 46,908,742,000 | 71,420,859,000 | 69,975,729,000 |
23028 | Cash Financial | 0 | 0 | 296,524,592,000 | 227,043,152,000 | 286,918,110,000 | 293,727,141,000 | 264,666,287,000 | 334,020,515,000 | 378,296,075,000 | 242,312,464,000 |
23179 | Prepaid Assets | 0 | 0 | 41,520,130,000 | 19,074,685,000 | 28,929,865,000 | 22,791,406,000 | 19,773,752,000 | 18,528,440,000 | 41,873,209,000 | 38,928,449,000 |
23232 | Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23385 | Working Capital | 0 | 0 | 1,002,281,056,000 | 936,651,976,000 | 989,991,784,000 | 1,077,471,753,000 | 1,020,934,540,000 | 965,629,768,000 | 931,560,214,000 | 844,398,351,000 |
23000 | Accounts Payable | 0 | 0 | 145,659,906,000 | 93,412,649,000 | 131,937,114,000 | 125,560,396,000 | 86,384,937,000 | 107,613,348,000 | 151,154,949,000 | 130,439,373,000 |
23029 | Cash Equivalents | 0 | 0 | 0 | 13,000,000,000 | 54,052,000,000 | 23,000,000,000 | 43,000,000,000 | 23,000,000,000 | 205,000,000,000 | 23,000,000,000 |
23245 | Invested Capital | 0 | 0 | 1,468,746,523,000 | 1,404,432,093,000 | 1,413,287,528,000 | 1,494,229,925,000 | 1,457,591,673,000 | 1,403,620,581,000 | 1,414,393,583,000 | 1,337,974,014,000 |
23340 | Other Properties | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,232,086,000 |
23342 | Other Receivables | 0 | 0 | 27,152,444,000 | 33,048,395,000 | 18,142,015,000 | 18,118,575,000 | 15,880,259,000 | 7,991,236,000 | 3,104,074,000 | 8,283,396,000 |
23204 | Retained Earnings | 0 | 0 | 1,141,577,661,000 | 1,074,088,554,000 | 1,075,731,190,000 | 1,159,584,758,000 | 1,124,187,069,000 | 1,063,272,189,000 | 1,043,817,178,000 | 986,441,951,000 |
23217 | Total Tax Payable | 0 | 0 | 68,021,686,000 | 36,358,381,000 | 16,714,246,000 | 28,569,007,000 | 43,944,734,000 | 6,664,460,000 | 12,818,182,000 | 34,092,271,000 |
23001 | Accounts Receivable | 0 | 0 | 773,968,571,000 | 696,169,487,000 | 512,938,764,000 | 667,095,914,000 | 642,263,276,000 | 556,433,743,000 | 468,412,673,000 | 708,985,205,000 |
23280 | Common Stock Equity | 0 | 0 | 1,468,746,523,000 | 1,404,432,093,000 | 1,413,287,528,000 | 1,494,229,925,000 | 1,457,591,673,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23403 | Net Tangible Assets | 0 | 0 | 1,397,584,785,000 | 1,332,046,002,000 | 1,339,677,084,000 | 1,419,395,128,000 | 1,381,532,523,000 | 1,344,862,569,000 | 1,333,924,920,000 | 1,322,942,778,000 |
23215 | Stockholders Equity | 0 | 0 | 1,468,746,523,000 | 1,404,432,093,000 | 1,413,287,528,000 | 1,494,229,925,000 | 1,457,591,673,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23383 | Tangible Book Value | 0 | 0 | 1,397,584,785,000 | 1,332,046,002,000 | 1,339,677,084,000 | 1,419,395,128,000 | 1,381,532,523,000 | 1,344,862,569,000 | 1,333,924,920,000 | 1,322,942,778,000 |
23374 | Total Capitalization | 0 | 0 | 1,468,746,523,000 | 1,404,432,093,000 | 1,413,287,528,000 | 1,494,229,925,000 | 1,457,591,673,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23312 | Land And Improvements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18,525,491,000 | 18,525,491,000 | 18,525,491,000 |
23393 | Ordinary Shares Number | 0 | 0 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 | 1,120,000,000 |
23395 | Treasury Shares Number | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23155 | Other Intangible Assets | 0 | 0 | 60,882,277,000 | 62,106,630,000 | 63,330,983,000 | 64,555,336,000 | 65,779,689,000 | 48,478,551,000 | 47,207,758,000 | 4,751,775,000 |
23008 | Accumulated Depreciation | 0 | 0 | -508,936,603,000 | -498,584,649,000 | -487,040,327,000 | -475,571,355,000 | -464,456,934,000 | -451,490,832,000 | -418,514,402,000 | -372,705,384,000 |
23282 | Construction In Progress | 0 | 0 | 51,125,507,000 | 36,169,619,000 | 42,042,578,000 | 28,813,839,000 | 25,609,379,000 | 14,258,424,000 | 30,895,540,000 | 78,569,561,000 |
23380 | Capital Lease Obligations | 0 | 0 | 1,368,209,000 | 1,474,205,000 | 1,579,145,000 | 1,683,037,000 | 1,785,893,000 | 1,887,723,000 | 0 | 988,532,000 |
23030 | Cash And Cash Equivalents | 0 | 0 | 296,524,592,000 | 240,043,152,000 | 340,970,110,000 | 316,727,141,000 | 307,666,287,000 | 357,020,515,000 | 583,296,075,000 | 265,312,464,000 |
23262 | Gross Accounts Receivable | 0 | 0 | 794,075,515,000 | 713,961,332,000 | 530,170,476,000 | 686,679,808,000 | 659,921,620,000 | 573,517,705,000 | 489,634,435,000 | 708,985,205,000 |
23012 | Additional Paid In Capital | 0 | 0 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 | 78,273,607,000 |
23275 | Buildings And Improvements | 0 | 0 | 398,555,966,000 | 392,529,005,000 | 377,429,210,000 | 375,113,925,000 | 372,490,900,000 | 369,245,422,000 | 364,694,534,000 | 347,821,296,000 |
23163 | Other Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,587,867,000 |
23020 | Available For Sale Securities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,788,789,000 | 5,922,548,000 | 40,910,882,000 |
23319 | Machinery Furniture Equipment | 0 | 0 | 486,802,192,000 | 487,496,308,000 | 463,785,086,000 | 458,263,486,000 | 457,508,585,000 | 449,900,041,000 | 405,653,146,000 | 362,262,802,000 |
23048 | Current Capital Lease Obligation | 0 | 0 | 434,778,000 | 430,440,000 | 426,146,000 | 421,893,000 | 417,684,000 | 413,517,000 | 0 | 988,532,000 |
23127 | Long Term Capital Lease Obligation | 0 | 0 | 933,431,000 | 1,043,765,000 | 1,152,999,000 | 1,261,144,000 | 1,368,209,000 | 1,474,206,000 | 0 | 0 |
23098 | Goodwill And Other Intangible Assets | 0 | 0 | 71,161,738,000 | 72,386,091,000 | 73,610,444,000 | 74,834,797,000 | 76,059,150,000 | 58,758,012,000 | 57,487,219,000 | 15,031,236,000 |
23261 | Total Equity Gross Minority Interest | 0 | 0 | 1,468,746,523,000 | 1,404,432,093,000 | 1,413,287,528,000 | 1,494,229,925,000 | 1,457,591,673,000 | 1,403,620,581,000 | 1,391,412,139,000 | 1,337,974,014,000 |
23259 | Total Liabilities Net Minority Interest | 0 | 0 | 731,660,903,000 | 637,739,728,000 | 594,439,444,000 | 602,138,721,000 | 595,738,974,000 | 605,518,904,000 | 691,499,183,000 | 645,441,561,000 |
23046 | Current Debt And Capital Lease Obligation | 0 | 0 | 434,778,000 | 430,440,000 | 426,146,000 | 421,893,000 | 417,684,000 | 413,517,000 | 22,981,444,000 | 988,532,000 |
23266 | Allowance For Doubtful Accounts Receivable | 0 | 0 | -20,106,944,000 | -17,791,845,000 | -17,231,712,000 | -19,583,894,000 | -17,658,344,000 | -17,083,962,000 | -21,221,762,000 | -22,611,115,000 |
23124 | Long Term Debt And Capital Lease Obligation | 0 | 0 | 933,431,000 | 1,043,765,000 | 1,152,999,000 | 1,261,144,000 | 1,368,209,000 | 1,474,206,000 | 0 | 0 |
23344 | Non Current Pension And Other Postretirement Benefit Plans | 0 | 0 | 145,071,535,000 | 132,366,556,000 | 149,559,128,000 | 145,198,526,000 | 138,696,119,000 | 121,700,955,000 | 96,397,484,000 | 89,598,040,000 |
Dataid | Breakdown | Seq | TTM | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|
26127 | Sale Of P P E | 0 | 7,297,726,000 | 2,458,887,000 | 3,223,301,000 | 3,505,581,000 | 2,230,377,000 |
26185 | Free Cash Flow | 0 | 117,298,060,000 | -55,567,753,000 | -76,273,500,000 | 350,219,943,000 | 43,776,630,000 |
26027 | Changes In Cash | 0 | -11,424,634,000 | -101,442,088,000 | -226,648,018,000 | 318,073,557,000 | -73,896,476,000 |
26182 | Issuance Of Debt | 0 | 0 | 0 | 29,463,719,000 | 69,819,951,000 | 0 |
26016 | End Cash Position | 0 | 296,241,653,000 | 240,043,152,000 | 357,020,515,000 | 583,296,075,000 | 265,312,464,000 |
26112 | Purchase Of P P E | 0 | -100,134,569,000 | -38,651,933,000 | -58,184,555,000 | -84,944,053,000 | -62,806,549,000 |
26183 | Repayment Of Debt | 0 | 0 | 0 | -52,790,038,000 | -46,698,820,000 | 0 |
26125 | Sale Of Investment | 0 | 0 | 0 | 0 | 69,725,000,000 | 0 |
26005 | Capital Expenditure | 0 | -100,134,569,000 | -38,651,933,000 | -60,213,400,000 | -84,944,053,000 | -62,806,549,000 |
26007 | Cash Dividends Paid | 0 | -135,520,000,000 | -48,160,000,000 | -129,920,000,000 | -125,440,000,000 | -119,840,000,000 |
26012 | Financing Cash Flow | 0 | -136,020,420,000 | -48,333,222,000 | -153,597,819,000 | -105,376,967,000 | -119,903,483,000 |
26013 | Investing Cash Flow | 0 | -92,836,843,000 | -36,193,046,000 | -56,990,099,000 | -11,713,472,000 | -60,576,172,000 |
26098 | Common Stock Issuance | 0 | 0 | 0 | 0 | 0 | 2,726,280,000 |
26015 | Beginning Cash Position | 0 | 307,666,287,000 | 340,970,110,000 | 583,296,075,000 | 265,312,464,000 | 339,047,459,000 |
26223 | Classesof Cash Payments | 0 | -1,533,452,571,000 | -357,455,511,000 | -1,818,061,168,000 | -1,577,151,141,000 | -1,535,618,228,000 |
26099 | Long Term Debt Issuance | 0 | 0 | 0 | 29,463,719,000 | 69,819,951,000 | 0 |
26090 | Long Term Debt Payments | 0 | 0 | 0 | -52,790,038,000 | -46,698,820,000 | 0 |
26108 | Purchase Of Intangibles | 0 | 0 | 0 | -2,028,845,000 | 0 | 0 |
26101 | Short Term Debt Issuance | 0 | 0 | 0 | 29,463,719,000 | 69,819,951,000 | 0 |
26091 | Short Term Debt Payments | 0 | 0 | 0 | -52,790,038,000 | -46,698,820,000 | 0 |
26181 | Issuance Of Capital Stock | 0 | 0 | 0 | 0 | 0 | 2,726,280,000 |
26071 | Net Common Stock Issuance | 0 | 0 | 0 | 0 | 0 | 2,726,280,000 |
26154 | Common Stock Dividend Paid | 0 | -135,520,000,000 | -48,160,000,000 | -129,920,000,000 | -125,440,000,000 | -119,840,000,000 |
26073 | Net Long Term Debt Issuance | 0 | 0 | 0 | -23,326,319,000 | 23,121,131,000 | 0 |
26119 | Net P P E Purchase And Sale | 0 | -92,836,843,000 | -36,193,046,000 | -54,961,254,000 | -81,438,472,000 | -60,576,172,000 |
26075 | Net Short Term Debt Issuance | 0 | 0 | 0 | -23,326,319,000 | 23,121,131,000 | 0 |
26072 | Net Issuance Payments Of Debt | 0 | 0 | 0 | -23,326,319,000 | 23,121,131,000 | 0 |
26226 | Paymentson Behalfof Employees | 0 | -420,624,358,000 | -100,409,406,000 | -392,329,179,000 | -379,924,397,000 | -325,401,112,000 |
26063 | Effect Of Exchange Rate Changes | 0 | 282,939,000 | 515,130,000 | 372,458,000 | -89,946,000 | 161,481,000 |
26118 | Net Investment Purchase And Sale | 0 | 0 | 0 | 0 | 69,725,000,000 | 0 |
26117 | Net Intangibles Purchase And Sale | 0 | 0 | 0 | -2,028,845,000 | 0 | 0 |
26222 | Other Cash Receiptsfrom Operating Activities | 0 | -2,034,343,000 | -22,104,038,000 | 14,404,888,000 | 7,808,007,000 | 8,539,011,000 |
26220 | Cash Flowsfromusedin Operating Activities Direct | 0 | 217,432,629,000 | -16,915,820,000 | -16,060,100,000 | 435,163,996,000 | 106,583,179,000 |
26221 | Classesof Cash Receiptsfrom Operating Activities | 0 | 1,786,444,293,000 | 341,551,653,000 | 1,860,534,077,000 | 2,092,624,511,000 | 1,696,349,112,000 |
Dataid | Breakdown | Seq | TTM | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|
26127 | Sale Of P P E | 0 | 7,297,726,000 | 1,253,473,000 | 2,458,887,000 | 1,274,741,000 | 2,310,625,000 | 977,061,000 | 3,223,301,000 | 3,505,581,000 | 2,230,377,000 |
26185 | Free Cash Flow | 0 | 117,298,060,000 | 55,407,333,000 | -55,567,753,000 | 110,405,517,000 | 7,052,963,000 | -50,620,902,000 | -76,273,500,000 | 350,219,943,000 | 43,776,630,000 |
26027 | Changes In Cash | 0 | -11,424,634,000 | 56,540,356,000 | -101,442,088,000 | 24,216,366,000 | 9,260,732,000 | -49,745,671,000 | -226,648,018,000 | 318,073,557,000 | -73,896,476,000 |
26182 | Issuance Of Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29,463,719,000 | 69,819,951,000 | 0 |
26016 | End Cash Position | 0 | 296,241,653,000 | 296,524,592,000 | 240,043,152,000 | 340,970,110,000 | 316,727,141,000 | 307,666,287,000 | 357,020,515,000 | 583,296,075,000 | 265,312,464,000 |
26112 | Purchase Of P P E | 0 | -100,134,569,000 | -28,576,150,000 | -38,651,933,000 | -21,607,738,000 | -11,298,748,000 | -26,357,541,000 | -58,184,555,000 | -84,944,053,000 | -62,806,549,000 |
26183 | Repayment Of Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -52,790,038,000 | -46,698,820,000 | 0 |
26125 | Sale Of Investment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69,725,000,000 | 0 |
26005 | Capital Expenditure | 0 | -100,134,569,000 | -28,576,150,000 | -38,651,933,000 | -21,607,738,000 | -11,298,748,000 | -26,357,541,000 | -60,213,400,000 | -84,944,053,000 | -62,806,549,000 |
26007 | Cash Dividends Paid | 0 | -135,520,000,000 | 0 | -48,160,000,000 | -133,280,000,000 | 0 | 0 | -129,920,000,000 | -125,440,000,000 | -119,840,000,000 |
26012 | Financing Cash Flow | 0 | -136,020,420,000 | -120,450,000 | -48,333,222,000 | -87,463,892,000 | -102,856,000 | -101,830,000 | -153,597,819,000 | -105,376,967,000 | -119,903,483,000 |
26013 | Investing Cash Flow | 0 | -92,836,843,000 | -27,322,677,000 | -36,193,046,000 | -20,332,997,000 | -8,988,123,000 | -25,380,480,000 | -56,990,099,000 | -11,713,472,000 | -60,576,172,000 |
26098 | Common Stock Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,726,280,000 |
26015 | Beginning Cash Position | 0 | 307,666,287,000 | 240,043,152,000 | 340,970,110,000 | 316,727,141,000 | 307,666,287,000 | 357,020,515,000 | 583,296,075,000 | 265,312,464,000 | 339,047,459,000 |
26223 | Classesof Cash Payments | 0 | -1,533,452,571,000 | -370,463,008,000 | -357,455,511,000 | -392,120,947,000 | -413,413,105,000 | -458,404,419,000 | -1,818,061,168,000 | -1,577,151,141,000 | -1,535,618,228,000 |
26099 | Long Term Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29,463,719,000 | 69,819,951,000 | 0 |
26090 | Long Term Debt Payments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -52,790,038,000 | -46,698,820,000 | 0 |
26108 | Purchase Of Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,028,845,000 | 0 | 0 |
26101 | Short Term Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29,463,719,000 | 69,819,951,000 | 0 |
26091 | Short Term Debt Payments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -52,790,038,000 | -46,698,820,000 | 0 |
26181 | Issuance Of Capital Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,726,280,000 |
26071 | Net Common Stock Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,726,280,000 |
26154 | Common Stock Dividend Paid | 0 | -135,520,000,000 | 0 | -48,160,000,000 | -133,280,000,000 | 0 | 0 | -129,920,000,000 | -125,440,000,000 | -119,840,000,000 |
26073 | Net Long Term Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23,326,319,000 | 23,121,131,000 | 0 |
26119 | Net P P E Purchase And Sale | 0 | -92,836,843,000 | -27,322,677,000 | -36,193,046,000 | -20,332,997,000 | -8,988,123,000 | -25,380,480,000 | -54,961,254,000 | -81,438,472,000 | -60,576,172,000 |
26075 | Net Short Term Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23,326,319,000 | 23,121,131,000 | 0 |
26072 | Net Issuance Payments Of Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23,326,319,000 | 23,121,131,000 | 0 |
26226 | Paymentson Behalfof Employees | 0 | -420,624,358,000 | -100,489,922,000 | -100,409,406,000 | -83,939,267,000 | -135,785,763,000 | -81,154,838,000 | -392,329,179,000 | -379,924,397,000 | -325,401,112,000 |
26063 | Effect Of Exchange Rate Changes | 0 | 282,939,000 | -58,916,000 | 515,130,000 | 26,603,000 | -199,878,000 | 391,443,000 | 372,458,000 | -89,946,000 | 161,481,000 |
26118 | Net Investment Purchase And Sale | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69,725,000,000 | 0 |
26117 | Net Intangibles Purchase And Sale | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,028,845,000 | 0 | 0 |
26222 | Other Cash Receiptsfrom Operating Activities | 0 | -2,034,343,000 | 382,334,000 | -22,104,038,000 | 12,712,409,000 | 6,974,952,000 | 10,456,286,000 | 14,404,888,000 | 7,808,007,000 | 8,539,011,000 |
26220 | Cash Flowsfromusedin Operating Activities Direct | 0 | 217,432,629,000 | 83,983,483,000 | -16,915,820,000 | 132,013,255,000 | 18,351,711,000 | -24,263,361,000 | -16,060,100,000 | 435,163,996,000 | 106,583,179,000 |
26221 | Classesof Cash Receiptsfrom Operating Activities | 0 | 1,786,444,293,000 | 459,296,110,000 | 341,551,653,000 | 534,177,054,000 | 451,419,476,000 | 435,654,610,000 | 1,860,534,077,000 | 2,092,624,511,000 | 1,696,349,112,000 |
Stock Code | Company Name | Date | Time | Previous Close | Open | Bid | Ask | Day's Range | Day's Range-Start | Day's Range-End | 52 Week Range | 52 Week Range-Start | 52 Week Range-End | Volume | Avg. Volume | Market Cap | Beta (5Y Monthly) | PE Ratio (TTM) | EPS (TTM) | Earnings Date | Forward Dividend & Yield | Forward Dividend | Forward Dividend Yield | Ex-Dividend Date | 1y Target Est | YTD Return |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-15 | At close: 04:03PM WIB | 1,500 | 1,500 | 1,455 | 1,460 | 1,450.00 - 1,525.00 | 1,450 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 240,100 | 51,586 | 1,630,000,000,000 | 0 | 11 | 131 | N/A | 121.00 (8.32%) | 121 | 8 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-12 | At close: 04:03PM WIB | 1,500 | 1,500 | 1,455 | 1,460 | 1,450.00 - 1,525.00 | 1,450 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 240,100 | 50,825 | 1,663,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-11 | At close: 04:03PM WIB | 1,500 | 1,500 | 1,455 | 1,460 | 1,450.00 - 1,525.00 | 1,450 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 240,100 | 50,041 | 1,663,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-10 | At close: 04:03PM WIB | 1,500 | 1,500 | 1,455 | 1,460 | 1,450.00 - 1,525.00 | 1,450 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 240,100 | 49,287 | 1,663,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-05 | At close: 04:03PM WIB | 1,500 | 1,500 | 1,460 | 1,400 | 1,450.00 - 1,525.00 | 1,450 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 240,100 | 44,794 | 1,663,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-04 | At close: 04:11PM WIB | 1,480 | 1,480 | 1,515 | 1,500 | 1,465.00 - 1,530.00 | 1,465 | 1,530 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 21,800 | 44,648 | 1,715,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-03 | At close: 03:26PM WIB | 1,500 | 1,500 | 1,480 | 1,495 | 1,480.00 - 1,505.00 | 1,480 | 1,505 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 29,600 | 44,925 | 1,692,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-02 | At close: 03:02PM WIB | 1,480 | 1,480 | 1,480 | 1,495 | 1,470.00 - 1,500.00 | 1,470 | 1,500 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 18,800 | 44,731 | 1,715,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-01 | At close: 03:49PM WIB | 1,460 | 1,475 | 1,475 | 1,485 | 1,470.00 - 1,490.00 | 1,470 | 1,490 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 29,300 | 44,682 | 1,692,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-29 | At close: 04:14PM WIB | 1,490 | 1,525 | 1,470 | 1,475 | 1,460.00 - 1,525.00 | 1,460 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 73,200 | 44,682 | 1,669,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-28 | At close: 04:14PM WIB | 1,490 | 1,525 | 1,470 | 1,475 | 1,460.00 - 1,525.00 | 1,460 | 1,525 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 73,200 | 43,768 | 1,635,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-27 | At close: 04:05PM WIB | 1,515 | 1,530 | 0 | 0 | 1,470.00 - 1,530.00 | 1,470 | 1,530 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 126,300 | 38,843 | 1,669,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-26 | At close: 04:12PM WIB | 1,510 | 1,500 | 0 | 0 | 1,480.00 - 1,530.00 | 1,480 | 1,530 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 51,800 | 39,281 | 1,697,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-25 | At close: 04:11PM WIB | 1,390 | 1,400 | 0 | 0 | 1,400.00 - 1,540.00 | 1,400 | 1,540 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 152,200 | 39,970 | 1,691,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-22 | At close: 04:08PM WIB | 1,390 | 1,395 | 1,385 | 1,395 | 1,375.00 - 1,400.00 | 1,375 | 1,400 | 1,375.00 - 2,110.00 | 1,375 | 2,110 | 230,900 | 36,560 | 1,557,000,000,000 | 0 | 19 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-21 | At close: 04:02PM WIB | 1,395 | 0 | 0 | 0 | 0.0000 - 0.0000 | 0 | 0 | 0 | 0 | 34,937 | 0 | 0 | 0 | 74 | N/A | 121.00 (8.71%) | 121 | 9 | Nov 13, 2023 | 0 | |||
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-14 | As of 01:55PM WIB. Market open. | 1,465 | 1,475 | 1,450 | 1,465 | 1,435.00 - 1,480.00 | 1,435 | 1,480 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 40,100 | 27,682 | 1,613,000,000,000 | 0 | 19 | 74 | N/A | 121.00 (8.26%) | 121 | 8 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-13 | At close: 04:09PM WIB | 1,470 | 1,470 | 1,455 | 1,460 | 1,460.00 - 1,480.00 | 1,460 | 1,480 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 57,700 | 27,155 | 1,641,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.23%) | 121 | 8 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-11 | At close: 04:05PM WIB | 1,490 | 1,500 | 1,465 | 1,485 | 1,460.00 - 1,505.00 | 1,460 | 1,505 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 72,200 | 26,608 | 1,646,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.23%) | 121 | 8 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-08 | At close: 04:05PM WIB | 1,490 | 1,500 | 1,465 | 1,485 | 1,460.00 - 1,505.00 | 1,460 | 1,505 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 72,200 | 25,646 | 1,646,000,000,000 | 0 | 20 | 74 | N/A | 121.00 (8.12%) | 121 | 8 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-05 | At close: 04:04PM WIB | 1,590 | 1,620 | 1,555 | 1,585 | 1,550.00 - 1,620.00 | 1,550 | 1,620 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 148,000 | 21,891 | 1,742,000,000,000 | 0 | 22 | 72 | N/A | 121.00 (7.40%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-04 | At close: 03:46PM WIB | 1,635 | 1,595 | 1,605 | 1,620 | 1,575.00 - 1,635.00 | 1,575 | 1,635 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 53,000 | 22,048 | 1,781,000,000,000 | 0 | 21 | 74 | N/A | 121.00 (7.40%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-01 | At close: 04:05PM WIB | 1,630 | 1,635 | 1,620 | 1,635 | 1,600.00 - 1,635.00 | 1,600 | 1,635 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 44,900 | 21,727 | 1,831,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.42%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-28 | At close: 03:43PM WIB | 1,645 | 1,645 | 1,640 | 1,650 | 1,640.00 - 1,650.00 | 1,640 | 1,650 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 9,200 | 21,428 | 1,837,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.36%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-27 | At close: 02:59PM WIB | 1,645 | 1,645 | 1,645 | 1,650 | 1,640.00 - 1,645.00 | 1,640 | 1,645 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 6,300 | 21,862 | 1,842,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.36%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-26 | At close: 02:18PM WIB | 1,650 | 1,635 | 1,640 | 1,650 | 1,635.00 - 1,650.00 | 1,635 | 1,650 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 13,100 | 22,193 | 1,842,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.33%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-23 | At close: 02:44PM WIB | 1,645 | 1,650 | 1,645 | 1,650 | 1,645.00 - 1,655.00 | 1,645 | 1,655 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 7,400 | 22,277 | 1,848,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.36%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk (DVLA.JK) | 2024-02-22 | At close: 03:44PM WIB | 1,655 | 1,650 | 1,645 | 1,655 | 1,645.00 - 1,655.00 | 1,645 | 1,655 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 33,400 | 22,249 | 1,842,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.31%) | 121 | 7 | Nov 13, 2023 | 0 | |
DVLA | PT Darya-Varia Laboratoria Tbk (DVLA.JK) | 2024-02-21 | At close: 04:04PM WIB | 1,650 | 1,650 | 1,650 | 1,665 | 1,645.00 - 1,660.00 | 1,645 | 1,660 | 1,400.00 - 2,110.00 | 1,400 | 2,110 | 14,100 | 22,127 | 1,854,000,000,000 | 0 | 22 | 74 | N/A | 121.00 (7.33%) | 121 | 7 | Nov 13, 2023 | 0 |
Stock Code | Company Name | Date | Market Cap (intraday) | Enterprise Value | Trailing P/E | Forward P/E | PEG Ratio (5 Yr Expected) | Price/Sales (ttm) | Price/Book (mrq) | Enterprise Value/Revenue | Enterprise Value/EBITDA | Beta (5Y Monthly) | 52-Week Change | S&P500 52-Week Change | 52 Week High | 52 Week Low | 50-Day Moving Average | 200-Day Moving Average | Avg Vol (3 Month) | Avg Vol (10 Day) | Shares Outstanding | Implied Shares Outstanding | Float | % Held By Insiders | % Held By Institutions | Shares Short | Short Ratio | Short % Of Float | Short % Of Shares Outstanding | Shares Short (prior Month) | Forward Annual Dividend Rate | Forward Annual Dividend Yield | Trailing Annual Dividend Rate | Trailing Annual Dividend Yield | 5 Year Average Dividend Yield | Payout Ratio | Dividend Date | Ex-Dividend Date | Last Split Factor | Last Split Date | Fiscal Year Ends | Most Recent Quarter (mrq) | Profit Margin | Operating Margin (ttm) | Return On Assets (ttm) | Return On Equity (ttm) | Revenue (ttm) | Revenue Per Share (ttm) | Quarterly Revenue Growth (yoy) | Gross Profit (ttm) | EBITDA | Net Income Avi To Common (ttm) | Diluted EPS (ttm) | Quarterly Earnings Growth (yoy) | Total Cash (mrq) | Total Cash Per Share (mrq) | Total Debt (mrq) | Total Debt/Equity (mrq) | Current Ratio (mrq) | Book Value Per Share (mrq) | Operating Cash Flow (ttm) | Levered Free Cash Flow (ttm) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-15 | 1,630,000,000,000 | 1,390,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 1,375 | 1,541 | 1,778 | 51 | 68 | 1,120,000,000 | 0 | 88,260,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 8 | 0 | 0 | 5 | 92 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2023 | Dec 31, 2023 | 8 | 11 | 6 | 10 | 1,890,000,000,000 | 1,688 | 39 | 0 | 247,360,000,000 | 146,340,000,000 | 131 | 0 | 240,040,000,000 | 214 | 1,470,000,000 | 0 | 3 | 1,254 | 109,190,000,000 | -8,000,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-12 | 1,630,000,000,000 | 1,390,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 1,375 | 1,554 | 1,786 | 50 | 77 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-11 | 1,630,000,000,000 | 1,390,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 1,375 | 1,554 | 1,786 | 49 | 77 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-10 | 1,630,000,000,000 | 1,390,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 1,375 | 1,554 | 1,786 | 49 | 77 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-05 | 1,660,000,000,000 | 1,420,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 0 | 1,575 | 1,798 | 45 | 91 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-04 | 1,680,000,000,000 | 1,440,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 0 | 1,579 | 1,801 | 45 | 103 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-03 | 1,680,000,000,000 | 1,440,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 0 | 1,583 | 1,803 | 45 | 128 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-02 | 1,660,000,000,000 | 1,420,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 0 | 1,587 | 1,806 | 45 | 133 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-04-01 | 1,640,000,000,000 | 1,400,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 0 | 1,587 | 1,806 | 45 | 133 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-29 | 1,640,000,000,000 | 1,400,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 1,375 | 1,592 | 1,809 | 44 | 139 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-28 | 1,670,000,000,000 | 1,430,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 0 | 2,110 | 0 | 1,591 | 1,810 | 39 | 112 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-27 | 1,560,000,000,000 | 1,320,000,000,000 | 11 | 0 | 0 | 1 | 1 | 1 | 9 | 0 | 0 | 0 | 2,110 | 0 | 1,597 | 1,813 | 39 | 124 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-26 | 1,560,000,000,000 | 1,220,000,000,000 | 19 | 0 | 0 | 1 | 1 | 1 | 8 | 0 | 0 | 0 | 2,110 | 0 | 1,603 | 1,816 | 40 | 140 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 9 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-25 | 1,560,000,000,000 | 1,220,000,000,000 | 19 | 0 | 0 | 1 | 1 | 1 | 8 | 0 | 0 | 0 | 2,110 | 1,375 | 1,603 | 1,816 | 40 | 140 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 9 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-22 | 1,560,000,000,000 | 1,220,000,000,000 | 19 | 0 | 0 | 1 | 1 | 1 | 8 | 0 | 0 | 0 | 2,110 | 0 | 1,615 | 1,822 | 35 | 117 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 9 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-21 | 1,560,000,000,000 | 1,220,000,000,000 | 19 | 0 | 0 | 1 | 1 | 1 | 8 | 0 | 0 | 0 | 2,110 | 1,385 | 1,615 | 1,822 | 35 | 117 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 9 | 121 | 9 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-14 | 1,640,000,000,000 | 1,300,000,000,000 | 20 | 0 | 0 | 1 | 1 | 1 | 8 | 0 | 0 | 0 | 2,110 | 0 | 1,646 | 1,838 | 27 | 64 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 8 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-13 | 1,650,000,000,000 | 1,310,000,000,000 | 20 | 0 | 0 | 1 | 1 | 1 | 9 | 0 | 0 | 0 | 2,110 | 0 | 1,653 | 1,843 | 27 | 53 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 8 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-11 | 1,650,000,000,000 | 1,310,000,000,000 | 20 | 0 | 0 | 1 | 1 | 1 | 9 | 0 | 0 | 0 | 2,110 | 1,400 | 1,653 | 1,843 | 26 | 53 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 8 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-08 | 1,670,000,000,000 | 1,330,000,000,000 | 20 | 0 | 0 | 1 | 1 | 1 | 9 | 0 | 0 | 0 | 2,110 | 1,400 | 1,657 | 1,846 | 26 | 46 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 8 | 121 | 8 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-05 | 1,830,000,000,000 | 1,490,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 0 | 1,666 | 1,854 | 22 | 16 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 72 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-04 | 1,830,000,000,000 | 1,490,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 1,400 | 1,666 | 1,854 | 22 | 16 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-03-01 | 1,830,000,000,000 | 1,490,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 0 | 1,667 | 1,858 | 21 | 15 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-28 | 1,840,000,000,000 | 1,500,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 0 | 1,668 | 1,861 | 22 | 17 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-27 | 1,840,000,000,000 | 1,500,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 0 | 1,668 | 1,862 | 22 | 16 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk | 2024-02-26 | 1,850,000,000,000 | 1,510,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 0 | 1,668 | 1,862 | 22 | 16 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk (DVLA.JK) | 2024-02-23 | 1,840,000,000,000 | 1,500,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 0 | 1,668 | 1,865 | 22 | 14 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk (DVLA.JK) | 2024-02-22 | 1,850,000,000,000 | 1,510,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 1,400 | 1,668 | 1,865 | 22 | 14 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
DVLA | PT Darya-Varia Laboratoria Tbk (DVLA.JK) | 2024-02-21 | 1,850,000,000,000 | 1,510,000,000,000 | 22 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 0 | 0 | 2,110 | 1,400 | 1,668 | 1,867 | 22 | 18 | 1,120,000,000 | 0 | 88,200,000 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 7 | 121 | 7 | 5 | 161 | N/A | Nov 13, 2023 | 2:1 | Nov 12, 2010 | Dec 31, 2022 | Sep 30, 2023 | 5 | 0 | 4 | 6 | 1,740,000,000,000 | 1,553 | -17 | 0 | 179,940,000,000 | 83,900,000,000 | 74 | 0 | 340,970,000,000 | 304 | 1,580,000,000 | 0 | 3 | 1,262 | 164,010,000,000 | 61,640,000,000 |
Stock Price (1 Minute)
| Stock Price (2 Minutes)
| Stock Price (5 Minutes)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Price (15 Minutes)
| Stock Price (30 Minutes)
| Stock Price (30 Minutes)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Price (90 Minutes)
| Stock Price (1 Day)
| Stock Price (5 Days)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Price (1 Week)
| Stock Price (1 Month)
| Stock Price (3 Months)
|
Dividends Amount
| Dividends Yields
| SplitsN/A |
Disclaimer This website is intended for informational purposes only. We do not provide any buying or selling recommendations or investment advice regarding stocks or any other financial instruments. The content provided on this website is for educational and informational purposes and should not be considered as financial advice. Investing in stocks or any financial asset carries risks, and individuals should conduct their own research or consult with a qualified financial advisor before making any investment decisions. The information provided on this website may not be suitable for all individuals, and we do not guarantee the accuracy, completeness, or reliability of the information presented. Any opinions, analyses, reviews, or recommendations expressed on this website are solely those of the authors and do not represent the opinions or endorsements of any company or entity. We do not endorse or promote any specific stocks, investment strategies, or financial products. By using this website, you agree that you are solely responsible for any investment decisions you make, and you agree to indemnify and hold harmless this website and its owners, operators, and affiliates from any losses, damages, or liabilities arising from your use of the information provided. Please be aware that past performance is not indicative of future results, and investing in the financial markets involves inherent risks. We encourage you to exercise caution and prudence when making investment decisions and to seek professional advice as needed.
Free-Counters